| Mariarita Salvitti Fermin, MD | |
|
1601 Center St, Mobile, AL 36604-1541 | |
| (251) 410-5437 | |
| (251) 410-5437 |
| Full Name | Mariarita Salvitti Fermin |
|---|---|
| Gender | Female |
| Speciality | Urology - Pediatric Urology |
| Location | 1601 Center St, Mobile, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225438666 | NPI | - | NPPES |
| 20412700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2088P0231X | Urology - Pediatric Urology | ME131447 (Florida) | Secondary |
| 2088P0231X | Urology - Pediatric Urology | L.5565SP (Alabama) | Primary |
| Entity Name | Pediatrix Medical Group Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083711790 PECOS PAC ID: 4486634417 Enrollment ID: O20040721000998 |
News Archive
The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).
Cigarette smoking and nicotine addiction are widespread problems throughout the world. Many people continue to smoke despite high taxes and the available public information on the dangers of smoking.
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
"Research evidence has undoubtedly been crucial in formulating countless global health policies which have saved many millions of lives," but "at the same time, we believe there are several common fallacies about its 'real world' application," Gavin Yamey and Richard Feachem of the Evidence to Policy initiative write in an Evidence-Based Medicine perspective.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mariarita Salvitti Fermin, MD Po Box 746450, Atlanta, GA 30374-6450 Ph: (251) 434-3626 | Mariarita Salvitti Fermin, MD 1601 Center St, Mobile, AL 36604-1541 Ph: (251) 410-5437 |
News Archive
The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).
Cigarette smoking and nicotine addiction are widespread problems throughout the world. Many people continue to smoke despite high taxes and the available public information on the dangers of smoking.
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
"Research evidence has undoubtedly been crucial in formulating countless global health policies which have saved many millions of lives," but "at the same time, we believe there are several common fallacies about its 'real world' application," Gavin Yamey and Richard Feachem of the Evidence to Policy initiative write in an Evidence-Based Medicine perspective.
› Verified 8 days ago
Zachary David Reardon, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 | |
Selden Harbour Stephens Iii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 | |
Dr. Thomas W Coleman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Ste B111, Mobile, AL 36608 Phone: 251-378-3000 Fax: 251-378-3001 | |
Dino Nicholas Frangos, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 | |
Guy Coleman Oswalt Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 | |
Paul Anthony Scott Sr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 168 Mobile Infirmary Blvd, Mobile, AL 36607 Phone: 251-433-1895 Fax: 251-433-1917 |